<DOC>
	<DOCNO>NCT01316601</DOCNO>
	<brief_summary>Test safety efficacy novel IL-13 AB treatment perianal fistula - Trial medicinal product</brief_summary>
	<brief_title>A Study Assess Efficacy , Safety Tolerability Anti-IL-13 Monoclonal Antibody QAX576 Treatment Perinanal Fistulas Patients Suffering From Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Inclusion criterion : diagnosis Crohn 's disease &gt; 6 month fistula least 1 ineffective fistula treatment past Exclusion criterion : TNF antibody treatment fail past plan surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>